(Q42235469)

19 October 2017

title

Longitudinal immune responses and gene expression profiles in type 1 leprosy reactions (English)

1 reference

19 October 2017

0 references

Karin Dijkman

8

0 references

Tom H M Ottenhoff

13

object named as

Tom H M Ottenhoff

1 reference

19 October 2017

1

Annemieke Geluk

1 reference

19 October 2017

9

Kees L M C Franken

1 reference

19 October 2017

4

Kidist Bobosha

1 reference

19 October 2017

Krista E van Meijgaarden

2

object named as

Krista E van Meijgaarden

1 reference

19 October 2017

11

Mariëlle C Haks

1 reference

19 October 2017

Louis Wilson

3

1 reference

19 October 2017

Jolien J van der Ploeg-van Schip

5

1 reference

19 October 2017

Susan J F van den Eeden

6

1 reference

19 October 2017

Edwin Quinten

7

1 reference

19 October 2017

Elisabeth M Haisma

10

1 reference

19 October 2017

Colette L M van Hees

12

1 reference

19 October 2017

publication date

27 December 2013

1 reference

Journal of Clinical Immunology

19 October 2017

published in

1 reference

19 October 2017

volume

34

1 reference

19 October 2017

issue

2

1 reference

19 October 2017

page(s)

245-255

1 reference

https://scigraph.springernature.com/pub.10.1007/s10875-013-9979-x

19 October 2017

exact match

0 references

cites work

Borderline lepromatous leprosy in an Italian man.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Cytokine and protein markers of leprosy reactions in skin and nerves: baseline results for the North Indian INFIR cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Diagnosis and treatment of leprosy reactions in integrated services--the patients' perspective in Nepal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Increased CXC ligand 10 levels and gene expression in type 1 leprosy reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Sequential erythema nodosum leprosum and reversal reaction with similar lesional cytokine mRNA patterns in a borderline leprosy patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Challenges in immunodiagnostic tests for leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Serum levels of interferon-gamma, tumour necrosis factor-alpha, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

An unbiased genome-wide Mycobacterium tuberculosis gene expression approach to discover antigens targeted by human T cells expressed during pulmonary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

HLA-E expression in cervical adenocarcinomas: association with improved long-term survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Human beta-defensin 3 is up-regulated in cutaneous leprosy type 1 reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

New pathways of protective and pathological host defense to mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Genomewide association study of leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

CD39 is involved in mediating suppression by Mycobacterium bovis BCG-activated human CD8(+) CD39(+) regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Beneficial effects of sitostanol on the attenuated immune function in asthma patients: results of an in vitro approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Progesterone suppresses the mTOR pathway and promotes generation of induced regulatory T cells with increased stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

T-cell release of granulysin contributes to host defense in leprosy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Circulating levels of insulin-like growth factor-I (IGF-I) correlate with disease status in leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-013-9979-X

Single-patient randomised clinical trial. Use in determining optimum treatment for patient with inflammation of Kock continent ileostomy reservoir

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India

1 reference

12 December 2020

1 reference

12 December 2020

Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states

1 reference

12 December 2020

Classification of leprosy according to immunity. A five-group system

1 reference

12 December 2020

10.1007/S10875-013-9979-X

Identifiers

DOI

1 reference

Dimensions Publication ID

19 October 2017

1002952092

0 references

1 reference